drugset / Trial / NCT03068897

Ibuprofen Plus Metaxolone, Tizanidine, or Baclofen for Low Back Pain

NCT03068897

Phase 4 Completed 320 enrolled Montefiore Medical Center
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a randomized study, based in emergency departments, in which the investigators determine the utility of adding various skeletal muscle relaxants to standard therapy, which consists of ibuprofen and an educational session. Patients will be enrolled at the time of an emergency visit and followed for three months to determine outcomes.

Timeline

Start
2017-05-03
Primary completion
2018-07-11
Completion
2018-10-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Baclofen Small molecule 10 mg
Comparator Baclofen Small molecule 20 mg
Comparator Metaxalone Small molecule 400 mg
Comparator Metaxalone Small molecule 800 mg
Comparator Tizanidine Small molecule 2 mg
Comparator Tizanidine Small molecule 4 mg
Comparator Ibuprofen Small molecule 600 mg

Indications

No indication recorded.